One of the pioneers of in vivo cell therapy, Umoja Biopharma, has cleared another regulatory milestone after getting a fast-track designation from the FDA for its lead candidate for blood cancers, ...
From cancer to Alzheimer’s: could a renewed focus on energy transform biomedicine? Including energy dynamics in research could improve our understanding of diseases and of the healing processes that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results